Avior Wealth Management’s Edesa Biotech EDSA Stock Holding History

Avior Wealth Management’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1	Closed	–	–	740
2018 Q2	$0	Buy	+1	New	+$143	﹤0.01%	801

Other funds holding EDSA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Avior Wealth Management's EDSA Position: Q3 2018 in Review

Avior Wealth Management sold out of Edesa Biotech (EDSA) in Q3 2018, closing a stake of 1 share.

Avior Wealth Management first reported a position in EDSA in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 17 funds tracked by Wall St. Rank hold EDSA as of Q3 2018.

Avior Wealth Management reported no remaining Edesa Biotech position as of Q3 2018 after selling out during the quarter.
Avior Wealth Management sold 1 Edesa Biotech share in Q3 2018.
Avior Wealth Management first reported a position in Edesa Biotech in Q2 2018 and held it in 1 quarter.
Avior Wealth Management's Edesa Biotech position peaked at $0 in Q2 2018.
17 funds tracked by Wall St. Rank held Edesa Biotech as of Q3 2018.

Based on Avior Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.